High Inpatient Dose of Opioid at Discharge Compared to Home Dose Predicts Readmission Risk in Sickle Cell Disease

American Journal of Hematology - United States
doi 10.1002/ajh.25311
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Opioid Dose and Risk of Suicide

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2016English

High-Dose Chemotherapy in High-Risk Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

A Phase 1 Dose-Finding Study of Intravenous L-Citrulline in Sickle Cell Disease: A Potential Novel Therapy for Sickle Cell Pain Crisis

British Journal of Haematology
Hematology
2018English

Single High-Dose Buprenorphine for Opioid Craving During Withdrawal

Trials
MedicinePharmacology
2018English

“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia

American Journal of Hematology
Hematology
2019English

A Comment on Pattern of Opioid Use in Sickle Cell Disease

American Journal of Hematology
Hematology
2017English

Opioid Utilization Patterns in United States Individuals With Sickle Cell Disease

American Journal of Hematology
Hematology
2018English

High-Dose Opioid Use and Liver Transplantation: An Underestimated Problem?

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Predictors of Acute Care Utilization and Acute Pain Treatment Outcomes in Adults With Sickle Cell Disease: The Role of Non-Hematologic Characteristics and Baseline Chronic Opioid Dose

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy